SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PARMEGGIANI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.278
EU - Europa 6.973
AS - Asia 5.133
SA - Sud America 953
AF - Africa 98
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.054
IT - Italia 3.577
SG - Singapore 2.032
CN - Cina 1.428
BR - Brasile 770
DE - Germania 705
UA - Ucraina 618
PL - Polonia 615
HK - Hong Kong 572
GB - Regno Unito 396
VN - Vietnam 337
TR - Turchia 324
FI - Finlandia 314
FR - Francia 167
RU - Federazione Russa 166
SE - Svezia 111
MX - Messico 106
CA - Canada 98
ID - Indonesia 88
NL - Olanda 79
IN - India 75
AR - Argentina 71
JP - Giappone 62
ZA - Sudafrica 39
EC - Ecuador 36
BD - Bangladesh 35
BE - Belgio 33
TH - Thailandia 33
ES - Italia 31
CO - Colombia 29
AT - Austria 28
RO - Romania 24
CZ - Repubblica Ceca 20
AU - Australia 19
CH - Svizzera 19
IQ - Iraq 18
LT - Lituania 17
KR - Corea 15
EG - Egitto 14
IL - Israele 13
KE - Kenya 13
UZ - Uzbekistan 13
CL - Cile 11
PT - Portogallo 10
MY - Malesia 9
PY - Paraguay 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
IR - Iran 8
PE - Perù 8
AL - Albania 7
JO - Giordania 7
AZ - Azerbaigian 6
BG - Bulgaria 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
GR - Grecia 6
NP - Nepal 6
PK - Pakistan 6
SA - Arabia Saudita 6
TN - Tunisia 6
UY - Uruguay 6
MA - Marocco 5
NZ - Nuova Zelanda 5
PH - Filippine 5
TW - Taiwan 5
EU - Europa 4
RS - Serbia 4
BO - Bolivia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MW - Malawi 3
NG - Nigeria 3
OM - Oman 3
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
IE - Irlanda 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
PA - Panama 2
QA - Qatar 2
SM - San Marino 2
SN - Senegal 2
TJ - Tagikistan 2
TZ - Tanzania 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
Totale 23.451
Salva come PNG Salva come JPEG
Città #
Singapore 1.132
Fairfield 1.063
Woodbridge 977
Ashburn 956
Jacksonville 660
Houston 652
Warsaw 606
Hong Kong 559
Chandler 515
Santa Clara 479
Beijing 462
Seattle 415
Wilmington 397
Ann Arbor 396
Milan 357
Cambridge 349
Munich 274
Dallas 251
Izmir 235
Rome 199
Nanjing 181
Princeton 157
Los Angeles 151
Helsinki 132
Boardman 118
Ferrara 109
Bologna 103
Ho Chi Minh City 101
New York 91
San Diego 84
Mexico City 69
Shenyang 67
São Paulo 66
Shanghai 63
Hanoi 58
Jakarta 57
Naples 56
Dong Ket 54
Palermo 54
Hefei 50
Redwood City 50
Nanchang 49
Bari 47
Jiaxing 46
Tokyo 45
Florence 43
London 43
Turku 43
Chicago 40
Turin 39
Brooklyn 37
Tianjin 37
Verona 37
Changsha 36
Catania 35
Moscow 35
Montreal 34
Hebei 32
Bremen 29
Denver 27
Brussels 26
Dearborn 26
Chennai 25
Padova 25
Addison 24
Falkenstein 24
Mountain View 24
Norwalk 23
Toronto 23
Boston 22
Pescara 22
Guangzhou 21
Haiphong 21
Kunming 21
San Francisco 21
Stockholm 21
Buffalo 20
Genoa 20
Johannesburg 20
Poplar 19
Rio de Janeiro 19
Cagliari 18
Jinan 18
San Mateo 18
Ankara 17
Atlanta 17
Belo Horizonte 17
Brasília 17
Tampa 17
Zhengzhou 17
Catanzaro 16
Council Bluffs 16
Falls Church 16
Phoenix 15
Quito 15
Timisoara 15
Manchester 14
Messina 14
Napoli 14
Frankfurt am Main 13
Totale 14.310
Salva come PNG Salva come JPEG
Nome #
EPIDEMIOLOGIA, DIAGNOSI E TRATTAMENTO DELLA COMPLICANZA NEOVASCOLARE SOTTORETINICA 1.440
La gestione clinica e riabilitativa del paziente ipovedente 872
Fattori di crescita e cellule staminali 532
Ibuprofen oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma 531
PATOLOGIE OCULARI IN RELAZIONE CON LE PROBLEMATICHE DELL’IPOVISIONE 412
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study 357
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 341
A novel mutation of BEST1 gene in Best disease 260
Eredo-distrofia tapeto-retinica e miopia degenerativa: variabilità fenotipica familiare in tre pazienti di razza caucasica 258
ESAME DEL PAZIENTE AFFETTO DA IPOVISIONE 257
Psoriatic uveitis is not an exploded myth 252
Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study 250
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 227
Torsional phacoemulsification: A pilot study to revise the “harm scale” evaluating the endothelial damage and the visual acuity after cataract surgery 223
A pilot study to propose a "Harm Scale", a new method to predict risk of harm to the corneal endothelium caused by longitudinal phacoemulsification, and the subsequent effect of endothelial damage on post operative visual acuity 212
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 206
Bilateral isolated acute cataracts in three newly diagnosed insulin dependent diabetes mellitus young patients. 203
Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks 201
RETINOPATIA PIGMENTOSA: INQUADRAMENTO CLINICO E TERAPEUTICO 196
Genetic predictors of response to photodynamic therapy 187
Anatomical and functional results of patients with late-stage age-related macular degeneration 6 months after smaller-incision new-generation implantable miniature telescope (SING IMT™) implantation 175
PERDITA ENDOTELIALE DOPO ESTRAZIONE EXTRACAPSULARE DI CATARATTA E FACOEMULSIFICAZIONE IN SITU CON IMPIANTO DI LENTE INTRAOCULARE 174
Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia 171
Carbonic anhydrase inhibitor topical application and optic nerve head blood supply in primary open-angle glaucoma patients 169
Diabetic retinopathy and endothelin system: Microangiopathy versus endothelial dysfunction 169
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications 168
MicroRNAs as potential biomarkers and innovative therapeutic targets in retinal degenerations 168
Central serous chorioretinopathy: Pathogenesis and management 158
Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation 150
Attualita sulla retinite pigmentosa 149
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update 149
Preferential hyperacuity perimetry: perspectives of self-monitoring of neovascular activity in patients with age-related macular degeneration 148
Aflibercept in wet AMD: specific role and optimal use 147
Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma 141
Epiretinal membrane in a 12-year-old immunocompetent girl with cytomegalovirus infection 140
Reproducibility of retinal thickness measurements with retinal thickness analyser in healthy and glaucomatous subjects 139
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 138
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 135
Effects of 0.005% latanoprost and 0.5% timolol on circadian intraocular pressure variations in patients with normal tension glaucoma 135
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 134
Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: A morphologic and functional study 128
BILATERAL CIRCUMSCRIBED HAEMANGIOMA OF THE CHOROID NOT ASSOCIATED WITH SYSTEMIC VASCULAR SYNDROME. 128
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal) 127
Inflammaging: should this term be suitable for age related macular degeneration too? 126
Eredo-degenerazioni tapeto-retiniche e cataratta. 125
LA QUALITÀ VISIVA NEI PAZIENTI CANDIDATI AD INTERVENTI DI CHIRURGIA RIFRATTIVA 123
Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system 123
One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study 121
null 120
TRATTAMENTO DEL PAZIENTE IPOVEDENTE 120
Topical nonsteroidal anti-inflammatory drugs for macular edema 119
Peripheral intrastromal hydration facilitates safe, deep trephination in corneas of irregular thickness 116
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 114
Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy 112
Gestione clinica della retinite pigmentosa: up-to.date. 108
null 107
Choroidal Changes in Myopic Eyes Affected by Choroidal Neovascularization 107
null 103
null 102
null 101
Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage 101
BILATERAL NEURORETINITIS IN A 6-YEAR-OLD BOY WITH ACQUIRED TOXOPLASMOSIS. 101
Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration 100
null 99
VEGF Levels in the Aqueous Humor of Patients With Wet AMD Treated With Intravitreal Bevacizumab. 99
ASSESSING THE COST-EFFECTIVENESS OF SWITCHING FROM A BETA-BLOCKER TO LATANOPROST IN THE TREATMENT OF OCULAR HYPERTENSION 98
null 97
null 97
12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration 97
null 97
Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene 96
null 95
null 95
The influence of diclofenac ophthalmic solution on the intraocular pressure lowering effect of 0.005% latanoprost in glaucomatous patients 95
null 95
null 94
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma 94
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. 93
Retinitis pigmentosa and cystoid macular pattern 92
null 92
null 92
null 91
Application of artificial intelligence in targeting retinal diseases 91
null 90
MODIFICAZIONI DELLA FLORA BATTERICA CONGIUNTIVALE, DEL FILM LACRIMALE E DEGLI ANNESSI OCULARI NEI PAZIENTI ACNEICI IN TERAPIA CON ISOTRETINOINA 90
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost 90
CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY ASSOCIATED WITH BILATERAL KERATOCONUS. 90
FACOMATOSI 90
Are visual disturbances (Excluding diabetic retinopathy) more common in geriatric dm patients? are they risks factor for the progression of disability? 90
Effetti della somministrazione topica di brinzolamide 1% sulla pressione di perfusione oculare e sugli indici perimetrici in pazienti in pazienti affetti da glaucoma primario ad angolo aperto: studio in acuto 89
null 88
null 88
Bilateral central serous chorioretinopathy in a patient treated with systemic cortico-steroids for non-Hodgkin lymphoma 88
X-Chromosome Insight for Targeting Gene Therapy 88
PATOLOGIE DELL’APPARATO VISIVO 87
null 87
null 86
null 86
null 86
null 86
Totale 16.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.916
Totale 103.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.430 0 0 0 0 0 250 96 284 89 281 259 171
2021/20221.648 84 147 144 65 63 70 94 77 59 131 181 533
2022/20231.518 185 59 71 157 249 215 67 124 188 42 92 69
2023/20241.444 123 145 86 81 95 106 93 91 53 164 136 271
2024/20254.305 199 142 320 182 440 407 253 297 673 498 518 376
2025/20265.392 965 497 963 1.334 1.485 148 0 0 0 0 0 0
Totale 23.720